EGA
AGN

E&G Advisors’s Allergan plc AGN Stock Holding History

E&G Advisors’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-6,257
Closed -$1.05M – 187
2019
Q2 		$1.05M Sell
6,257
-2,427
-28% -$336K 0.45% 56
2019
Q1 		$1.27M Sell
8,684
-924
-10% -$134K 0.56% 42
2018
Q4 		$1.28M Sell
9,608
-3,800
-28% -$623K 0.58% 40
2018
Q3 		$2.55M Sell
13,408
-603
-4% -$111K 0.97% 16
2018
Q2 		$2.34M Sell
14,011
-468
-3% -$75.1K 0.98% 17
2018
Q1 		$2.44M Buy
14,479
+1
+0% +$168 1.05% 17
2017
Q4 		$2.37M Sell
14,478
-1,505
-9% -$270K 1% 19
2017
Q3 		$3.28M Sell
15,983
-169
-1% -$39.3K 1.48% 14
2017
Q2 		$3.93M Sell
16,152
-628
-4% -$148K 1.89% 9
2017
Q1 		$4.01M Sell
16,780
-472
-3% -$110K 2.06% 7
2016
Q4 		$3.62M Sell
17,252
-1,188
-6% -$246K 2.15% 7
2016
Q3 		$4.25M Sell
18,440
-1,505
-8% -$368K 2.49% 6
2016
Q2 		$4.61M Sell
19,945
-118
-0.6% -$27.2K 2.8% 6
2016
Q1 		$5.38M Sell
20,063
-413
-2% -$118K 3.51% 6
2015
Q4 		$6.4M Buy
20,476
+900
+5% +$268K 3.84% 5
2015
Q3 		$5.32M Buy
19,576
+900
+5% +$276K 3.38% 5
2015
Q2 		$5.67M Buy
18,676
+975
+6% +$291K 3.31% 5
2015
Q1 		$5.27M Buy
17,701
+3,097
+21% +$883K 3.11% 5
2014
Q4 		$3.76M Sell
14,604
-320
-2% -$80K 2.44% 8
2014
Q3 		$3.6M Buy
14,924
+3,314
+29% +$742K 2.31% 6
2014
Q2 		$2.59M Buy
11,610
+2,420
+26% +$501K 1.67% 13
2014
Q1 		$1.89M Sell
9,190
-200
-2% -$39.6K 1.49% 18
2013
Q4 		$1.58M Buy
+9,390
New +$1.47M 1.48% 20

Other funds holding AGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
LP
Longview Partners St Peter Port, Guernsey $7.06B AUM 3.43% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

E&G Advisors's AGN Position: Q3 2019 in Review

E&G Advisors sold out of Allergan plc (AGN) in Q3 2019, closing a stake of 6,257 shares — an estimated $1.05M sold.

E&G Advisors first reported a position in AGN in Q4 2013 and held it in 23 quarters. The position peaked at $6.4M in Q4 2015. 921 funds tracked by Wall St. Rank hold AGN as of Q3 2019.

  • E&G Advisors reported no remaining Allergan plc position as of Q3 2019 after selling out during the quarter.
  • E&G Advisors sold 6,257 Allergan plc shares in Q3 2019, an estimated $1.05M.
  • E&G Advisors first reported a position in Allergan plc in Q4 2013 and held it in 23 quarters.
  • E&G Advisors's Allergan plc position peaked at $6.4M in Q4 2015.
  • 921 funds tracked by Wall St. Rank held Allergan plc as of Q3 2019.

Based on E&G Advisors's 13F filing for Q3 2019, filed 10 Oct 2019.